Carson Wealth (CWM LLC)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.83M Sell
11,580
-13,895
-55% -$4.73M 0.01% 925
2025
Q4
$10.1M Sell
25,475
-3,812
-13% -$1.69M 0.03% 526
2025
Q3
$13.4M Buy
29,287
+23,775
+431% +$9.68M 0.04% 379
2025
Q2
$1.8M Sell
5,512
-11,152
-67% -$3.09M 0.01% 992
2025
Q1
$4.5M Buy
16,664
+3,473
+26% +$893K 0.02% 558
2024
Q4
$3.1M Buy
13,191
+6,427
+95% +$1.69M 0.01% 610
2024
Q3
$1.86M Buy
6,764
+3,272
+94% +$852K 0.01% 737
2024
Q2
$849K Buy
3,492
+1,770
+103% +$279K ﹤0.01% 983
2024
Q1
$257K Sell
1,722
-41,678
-96% -$6.95M ﹤0.01% 1398
2023
Q4
$8.31M Sell
43,400
-538
-1% -$91.6K 0.04% 295
2023
Q3
$7.78M Sell
43,938
-1,436
-3% -$274K 0.05% 280
2023
Q2
$8.62M Buy
45,374
+43,648
+2,529% +$8.65M 0.05% 249
2023
Q1
$346K Sell
1,726
-193
-10% -$40.6K ﹤0.01% 1013
2022
Q4
$456K Sell
1,919
-1,044
-35% -$223K ﹤0.01% 837
2022
Q3
$593K Sell
2,963
-410
-12% -$78.2K ﹤0.01% 702
2022
Q2
$492K Sell
3,373
-6,579
-66% -$933K ﹤0.01% 737
2022
Q1
$1.63M Sell
9,952
-2,046
-17% -$312K 0.01% 444
2021
Q4
$2.04M Buy
+11,998
New +$2.23M 0.01% 428
2021
Q2
$2.02M Hold
11,896
0.02% 423
2021
Q1
$2.02M Hold
11,896
0.02% 423
2020
Q4
$2.02M Hold
11,896
0.02% 423
2020
Q3
$2.02M Hold
11,896
0.02% 423
2020
Q2
$2.02M Hold
11,896
0.02% 423
2020
Q1
$2.02M Hold
11,896
0.02% 423
2019
Q4
$2.02M Hold
11,896
0.02% 423
2019
Q3
$2.02M Hold
11,896
0.02% 423
2019
Q2
$2.02M Hold
11,896
0.02% 423
2019
Q1
$2.02M Buy
+11,896
New +$995K 0.02% 423

Other funds holding ALNY